Doctors and scientists at MSK have led the development of many of the drugs used to treat chronic myeloid leukemia. The first targeted therapy ever approved for CML, imatinib (Gleevec ®), was ...

Chronic myeloid leukemia (CML), a myeloproliferative neoplasm occurring in 1 to 2 adults per 100,000, accounts for some 15% of newly diagnosed cases of leukemia.

Explore the evolving treatment landscape of chronic myeloid leukemia with asciminib, a promising new TKI showing high ...

The investigators examined the records of 2857 patients with Ph+ CML diagnosed from 2000 to 2019. Their median age fell between 55 and 59 years of age, with 57% younger than age 60, 20% between ...

Hochhaus A, O’Brien SG, Guilhot F, et al. Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia. 2009;23:1054-1061.

Treatment of chronic myeloid leukemia aims at correcting blood counts in three months, clearing bone marrow of the cells containing Philadelphia chromosome by 12 months and taking the patient to a ...

Chronic myeloid leukemia (CML) is a type of blood cancer. CML is Philadelphia chromosome-positive (Ph+) when pieces of chromosomes 9 and 22 break off and swap places.

Chronic myeloid leukemia, or chronic myelogenous leukemia, is a type of cancer. It affects parts of the bone marrow that form immune cells, red blood cells, and platelets. If someone has chronic ...

Chronic myeloid leukemia (CML) is a type of cancer that causes blood cells to grow out of control. If you’ve been diagnosed with CML, it’s important to get treatment from healthcare ...

Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm characterized by an acquired balanced chromosomal translocation, which gives rise to a constitutively active tyrosine kinase (BCR-ABL1).